Frequency of CDH1, CTNNA1 and CTNND1 Germline Variants in Families with Diffuse and Mixed Gastric Cancer

被引：2

作者：

Guerra, Joana ^{[1
,2
]}

Pinto, Carla ^{[1
,3
,4
]}

Pinto, Pedro ^{[1
]}

Pinheiro, Manuela ^{[1
]}

Santos, Catarina ^{[1
,3
]}

Peixoto, Ana ^{[1
,3
]}

Escudeiro, Carla ^{[1
,3
]}

Barbosa, Ana ^{[1
,3
]}

Porto, Miguel ^{[1
]}

Francisco, Ines ^{[5
]}

Lopes, Paula ^{[6
]}

Isidoro, Ana Raquel ^{[6
]}

Cunha, Ana Luisa ^{[6
]}

Albuquerque, Cristina ^{[5
]}

Claro, Isabel ^{[7
,8
]}

Oliveira, Carla ^{[9
,10
,11
]}

Silva, Joao ^{[1
,12
]}

Teixeira, Manuel R. ^{[1
,3
,13
]}

机构：

[1] Portuguese Oncol Inst Porto IPO Porto, CI IPOP RISECI IPOP, Porto Res Ctr,Hlth Res Network, Porto Comprehens Canc Ctr,Canc Genet Grp, P-4200072 Porto, Portugal

[2] Univ Porto ICBAS UP, Sch Med & Biomed Sci, Doctoral Programme Biomed Sci, P-4050313 Porto, Portugal

[3] Portuguese Oncol Inst Porto IPO Porto, Porto Comprehens Canc Ctr, Dept Lab Genet, Porto, Portugal

[4] Polytech Inst Porto, Sch Hlth, Dept Pathol Cytolog & Thanatol Anat, P-4200072 Porto, Portugal

[5] Portuguese Oncol Inst Lisbon, Mol Pathobiol Res Unit, P-1099023 Lisbon, Portugal

[6] Portuguese Oncol Inst Porto IPO Porto, Porto Comprehens Canc Ctr PCCC, Dept Pathol, P-4200072 Porto, Portugal

[7] Portuguese Oncol Inst Lisbon, Gastroenterol Dept, P-1099023 Lisbon, Portugal

[8] Portuguese Oncol Inst Lisbon, Familiar Canc Risk Clin, P-1099023 Lisbon, Portugal

[9] i3S Inst Invest & Inovacao Saude, P-4200135 Porto, Portugal

[10] Univ Porto, IPATIMUP Inst Patol & Imunol Mol, P-4200135 Porto, Portugal

[11] Univ Porto FMUP, Fac Med, P-4100179 Porto, Portugal

[12] Portuguese Oncol Inst Porto IPO Porto, Porto Comprehens Canc Ctr, Med Genet Dept, P-4200072 Porto, Portugal

[13] Univ Porto, Sch Med & Biomed Sci ICBAS, P-4050313 Porto, Portugal

来源：

CANCERS | 2023年 / 15卷 / 17期

关键词：

hereditary diffuse gastric cancer; mixed gastric cancer; CDH1; gene; CTNNA1; CTNND1; MOLECULAR DIAGNOSIS; ALPHA-CATENIN; MUTATIONS; GUIDELINES; BREAST; SUSCEPTIBILITY; CARCINOMA; GENOMICS; ADHESION; MEMBERS;

D O I：

10.3390/cancers15174313

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Simple Summary: Hereditary diffuse gastric cancer (HDGC) is caused by germline pathogenic variants in the CDH1 and CTNNA1 genes and is characterized by a high prevalence of diffuse gastric cancer and lobular breast cancer. We aimed to evaluate the contribution of CTNNA1 and CTNND1 germline variants to HDGC, as well as to compare the frequencies of CDH1 and CTNNA1 (and eventually CTNND1) germline variants between patients with diffuse and mixed gastric carcinomas. In this study, we report a deleterious CTNNA1 germline variant and four CDH1 pathogenic variants in patients with criteria for genetic testing. None of the cases with mixed gastric cancer carried pathogenic variants in either the CDH1 or the CTNNA1 genes, so there is no evidence to use this tumor type in testing criteria. The most well-characterized hereditary form of gastric cancer is hereditary diffuse gastric cancer (HDGC), an autosomal dominant syndrome characterized by an increased risk of diffuse gastric and lobular breast cancer. HDGC is predominantly caused by germline pathogenic variants in the CDH1 gene, and more rarely in the CTNNA1 gene. Furthermore, the International Gastric Cancer Linkage Consortium (IGCLC) guidelines do not clarify whether or not mixed gastric cancer (with a diffuse component) should be considered in the HDGC genetic testing criteria. We aimed to evaluate the contribution of CTNNA1 and CTNND1 germline variants to HDGC. Additionally, we also intended to compare the frequencies of CDH1 and CTNNA1 (and eventually CTNND1) germline variants between patients with diffuse and mixed gastric carcinomas to evaluate if genetic testing for these genes should or should not be considered in patients with the latter. We analyzed the CDH1 gene in 67 cases affected with early-onset/familial mixed gastric carcinomas and the CTNNA1 and CTNND1 genes in 208 cases with diffuse or mixed gastric cancer who had tested negative for CDH1 pathogenic germline variants. A deleterious CTNNA1 germline variant was found in 0.7% (1/141) of diffuse gastric cancer patients meeting the 2020 IGCLC criteria, as compared to the rate of 2.8% of CDH1 deleterious variants found by us in this setting. No deleterious variants were found in CTNND1, but six variants of uncertain significance were identified in this gene. We did not find any pathogenic CDH1, CTNNA1 or CTNND1 variant in index patients with early-onset/familial mixed gastric cancer, so there is no evidence that supports including this tumor type in the testing criteria for germline variants in these genes. The role of the CTNND1 gene in inherited gastric cancer predisposition is still unclear.

引用

页数：10